ABVC Biopharma, Inc. (ABVC) earnings
ABVC earnings moved a median of +1.33% by the close. Quarterly and annual ABVC reports and results, each read against the price at its own news timestamp. Back to the ABVC overview →
19 measured ABVC earnings events.
Where these ABVC earnings landedvs 19 measured ABVC earnings reactions
| Middle 50% of ABVC earnings reactions | -1.91% to +7.35% |
|---|---|
| Median reaction (to close) | +1.33% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 ABVC earnings events with a measured close landed between -1.91% and +7.35%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ABVC BIOPHARMA, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.84% | -1.09% | |
| Form 10-Q ABVC BIOPHARMA, INC. For: Mar 31 | SEC filing · Form 10-Q | +2.73% | -2.73% | |
| Form NT 10-Q ABVC BIOPHARMA, INC. For: Mar 31 | SEC filing · Form NT | +2.73% | -2.73% | |
| Form 10-K ABVC BIOPHARMA, INC. For: Dec 31 | SEC filing · Form 10-K | -0.70% | +1.40% | |
| Form 10-Q/A ABVC BIOPHARMA, INC. For: Sep 30 | SEC filing · Form 10-Q | -0.70% | +1.40% | |
| Form 10-Q ABVC BIOPHARMA, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +5.71% | |
| Form 10-Q ABVC BIOPHARMA, INC. For: Jun 30 | SEC filing · Form 10-Q | -0.33% | +1.33% | |
| Form 10-Q ABVC BIOPHARMA, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.97% | +0.00% | |
| Form 10-K ABVC BIOPHARMA, INC. For: Dec 31 | SEC filing · Form 10-K | +2.25% | +8.99% | |
| Form NT 10-K ABVC BIOPHARMA, INC. For: Dec 31 | SEC filing · Form NT | +1.75% | +15.79% | |
| Form 10-Q ABVC BIOPHARMA, INC. For: Sep 30 | SEC filing · Form 10-Q | +3.70% | +2.04% | |
| Form 10-Q ABVC BIOPHARMA, INC. For: Jun 30 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-Q ABVC BIOPHARMA, INC. For: Mar 31 | SEC filing · Form 10-Q | -1.76% | +0.00% | |
| Form NT 10-Q ABVC BIOPHARMA, INC. For: Mar 31 | SEC filing · Form NT | -1.82% | -3.64% | |
| Form 10-K/A ABVC BIOPHARMA, INC. For: Dec 31 | SEC filing · Form 10-K | -0.83% | -3.31% | |
| Form 10-K ABVC BIOPHARMA, INC. For: Dec 31 | SEC filing · Form 10-K | +0.43% | -3.23% | |
| ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results | Press release | +2.83% | +17.93% | |
| Form 10-Q ABVC BIOPHARMA, INC. For: Sep 30 | SEC filing · Form 10-Q | +2.83% | +17.93% | |
| Form NT 10-Q ABVC BIOPHARMA, INC. For: Sep 30 | SEC filing · Form NT | +2.83% | +17.93% |
Keep exploring
More ABVC: analyst actions → · SEC filings → · ABVC overview →